Physician profile
Gail W Luker
NPI 1851356760
$382.80
in general payments reported to CMS, 2019-2025
11 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $44.31 · 2023: $21.91 · 2024: $58.99 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $107.36 | 2021-2025 | Aptima |
| Organon LLC | $69.39 | 2023-2025 | Nexplanon |
| Gilead Sciences, INC. | $40.08 | 2024-2025 | Epclusa |
| Millicent US INC | $37.58 | 2025 | Femlyv, Intrarosa |
| Mylan Pharmaceuticals INC. | $30.49 | 2021-2022 | |
| Abbvie INC. | $19.96 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.73 | 2022 | |
| Glaxosmithkline, LLC. | $16.40 | 2024 | Shingrix, Arexvy |
| Siemens Medical Solutions USA, INC. | $15.86 | 2022 | |
| Exact Sciences Corporation | $15.19 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Luker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.